Bart Burington
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
-
- Glycosylation and Glycoproteins Research 5
- Protein Degradation and Inhibitors 3
- Hematology 11
- Multiple Myeloma Research and Treatments 8
- Chronic Myeloid Leukemia Treatments 3
- Co-authors
- Wayne Katon (4 shared papers)Jesse R. Fann (4 shared papers)John D. Shaughnessy (7 shared papers)John Crowley (6 shared papers)Bart Barlogie (7 shared papers)Fenghuang Zhan (6 shared papers)Robert S. Thompson (2 shared papers)Kenneth M. Jaffe (2 shared papers)
- Journals
- Blood (12 papers)Clinical Cancer Research (2 papers)Cancer (2 papers)Annals of the Rheumatic Diseases (2 papers)The Lancet Rheumatology (1 paper)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Bart Burington
31 papers receiving 2.2k citations
Bart Burington's Hit Papers
Peers
Comparison fields: 5 of 96
- Hematology 1.1k
- Genetics 248
- Critical Care and Intensive Care Medicine 102
- Oncology 466
- Emergency Medicine 135
Countries citing papers authored by Bart Burington
This map shows the geographic impact of Bart Burington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Burington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Burington more than expected).
Fields of papers citing papers by Bart Burington
This network shows the impact of papers produced by Bart Burington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Burington. The network helps show where Bart Burington may publish in the future.
Co-authors
The 25 scholars most cited alongside Bart Burington, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The molecular classification of multiple myeloma Hit paper breakdown → | 2006 | 811 |
| 2 | 2006 | 352 | |
| 3 | 2004 | 317 | |
| 4 | 2015 | 153 | |
| 5 | 2014 | 146 | |
| 6 | 2004 | 90 | |
| 7 | 2004 | 82 | |
| 8 | 2002 | 81 | |
| 9 | 2005 | 75 | |
| 10 | 2023 | 40 | |
| 11 | 2023 | 37 | |
| 12 | 2008 | 36 | |
| 13 | 2003 | 25 | |
| 14 | 2012 | 13 | |
| 15 | 2009 | 11 | |
| 16 | 2019 | 10 | |
| 17 | 2019 | 9 | |
| 18 | 2020 | 8 | |
| 19 | 2006 | 4 | |
| 20 | 2005 | 4 |
About Bart Burington
Bart Burington is a scholar working on Molecular Biology, Hematology, Genetics, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 32 papers that have together received 2.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Glycosylation and Glycoproteins Research (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Protein Degradation and Inhibitors (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Traumatic Brain Injury Research (2 papers). The work is most often cited by research in Hematology (1.1k citations), Genetics (248 citations), Critical Care and Intensive Care Medicine (102 citations), Oncology (466 citations) and Emergency Medicine (135 citations). Bart Burington has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Wayne Katon, Jesse R. Fann, John D. Shaughnessy, John Crowley, Bart Barlogie, Fenghuang Zhan, Robert S. Thompson, Kenneth M. Jaffe, Ichiro Hanamura and Klaus Hollmig. Their work appears in journals such as Blood, Clinical Cancer Research, Cancer, Annals of the Rheumatic Diseases and The Lancet Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.